| Q36733570 | 1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis |
| Q39230407 | A Pediatric Patient with a CYP24A1 Mutation: Four Years of Clinical, Biochemical, and Imaging Follow-Up |
| Q37616864 | A lifetime of hypercalcemia and hypercalciuria, finally explained |
| Q42698671 | A new look at vitamin D metabolism and "idiopathic" hypercalcemia |
| Q48349461 | A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass. |
| Q35762545 | Altered Calcium and Vitamin D Homeostasis in First-Time Calcium Kidney Stone-Formers |
| Q35813253 | CYP2R1 Mutations Impair Generation of 25-hydroxyvitamin D and Cause an Atypical Form of Vitamin D Deficiency. |
| Q51092138 | CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations. |
| Q54597198 | Chronic hypercalcaemia from inactivating mutations of vitamin D 24-hydroxylase (CYP24A1): implications for mineral metabolism changes in chronic renal failure. |
| Q89337281 | Clinical and biochemical phenotypes of adults with monoallelic and biallelic CYP24A1 mutations: evidence of gene dose effect |
| Q38588203 | Controversy and consensus regarding vitamin D: Recent methodological changes and the risks and benefits of vitamin D supplementation |
| Q47750453 | Coupling between phosphate and calcium homeostasis: a mathematical model |
| Q37590269 | Cytochrome P450-mediated metabolism of vitamin D. |
| Q36928922 | Cytochromes p450: roles in diseases |
| Q53215776 | Development and validation of the simultaneous measurement of four vitamin D metabolites in serum by LC-MS/MS for clinical laboratory applications. |
| Q38175288 | Exome sequencing greatly expedites the progressive research of Mendelian diseases |
| Q57315843 | Genetic Influences on Circulating Vitamin D Level: A Review |
| Q38785985 | Genetic Variants Associated with Circulating Parathyroid Hormone |
| Q64066212 | Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the Gene: A Case Report and Review of the Literature |
| Q36512912 | Human cytochromes P450 in health and disease |
| Q38616346 | Idiopathic infantile hypercalcemia: case report and review of the literature. |
| Q28088772 | Insights from exome sequencing for endocrine disorders |
| Q36911899 | Insights from genetic disorders of phosphate homeostasis |
| Q45810023 | Maternal and infantile hypercalcemia caused by vitamin-D-hydroxylase mutations and vitamin D intake |
| Q37265269 | Medullary nephrocalcinosis in an adult patient with idiopathic infantile hypercalcaemia and a novel CYP24A1 mutation |
| Q38029472 | Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders |
| Q46060960 | Prolonged vitamin D intoxication: presentation, pathogenesis and progress |
| Q35055101 | Quantitation of CYP24A1 enzymatic activity with a simple two-hybrid system |
| Q27011538 | Role of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis |
| Q42725856 | Ruling in a suspect: the role of AP2S1 mutations in familial hypocalciuric hypercalcemia type 3. |
| Q87354609 | Severe hypercalcemic crisis in an infant with idiopathic infantile hypercalcemia caused by mutation in CYP24A1 gene |
| Q42557653 | Take another CYP: confirming a novel mechanism for "idiopathic" hypercalcemia |
| Q30765921 | The struggle to find reliable results in exome sequencing data: filtering out Mendelian errors |
| Q88993393 | Using stable isotope tracers to study bone metabolism in children |
| Q38094123 | Vitamin D and metabolites measurement by tandem mass spectrometry |
| Q41640652 | Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment |